QNRX Quoin Pharmaceuticals, Ltd.
$4.01▼ -0.25%
Healthcare
Other
Volume 14.9K
Avg Volume (10D) 30.1K
Key Metrics & Fundamentals
Market Cap
$19.26M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.25 - 23.50
% vs 50 MA
-26.94%
% vs 200 MA
-35.30%
RSI-14
30.8
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.48
Free Cash Flow
-$3.14M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.45M
COGS
–
Operating Exp
$5.47M
Operating Income
-$5.47M
EBIT
-$5.47M
Pretax Income
-$5.37M
Net Income
-$5.37M
EPS (Diluted)
-1.90
Price & Volume History
Loading chart…
Recent News
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
GlobeNewswire · Oct 20, 2026 6:30 AM ET
Canaccord Genuity Initiates Quoin Pharmaceuticals at Buy With $18 Price Target
MT Newswires · Oct 19, 2026 5:35 AM ET
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
GlobeNewswire · Oct 14, 2026 6:30 AM ET
BTIG Initiates Quoin Pharmaceuticals at Buy With $14 Price Target
MT Newswires · Oct 12, 2026 7:38 AM ET
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
GlobeNewswire · Oct 6, 2026 6:30 AM ET
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
GlobeNewswire · Sep 22, 2026 8:30 AM ET
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
GlobeNewswire · Sep 10, 2026 8:30 AM ET
CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
GlobeNewswire · Sep 8, 2026 2:12 PM ET
Quoin in line for priority review voucher if rare paediatric drug approved
Pharmaceutical Technology · Sep 8, 2026 1:28 PM ET
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
GlobeNewswire · Sep 8, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See QNRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.